HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lin Chang Selected Research

Ischemic Colitis

11/2013An Evidence-Based Look at Misconceptions in the Treatment of Patients with IBS-D.
9/2013A 9-year evaluation of temporal trends in alosetron postmarketing safety under the risk management program.
4/2010Ischemic colitis and complications of constipation associated with the use of alosetron under a risk management plan: clinical characteristics, outcomes, and incidences.
5/2006Incidence of ischemic colitis and serious complications of constipation among patients using alosetron: systematic review of clinical trials and post-marketing surveillance data.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lin Chang Research Topics

Disease

29Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
12/2021 - 10/2002
12Constipation
01/2022 - 01/2005
12Diarrhea
01/2022 - 08/2002
11Atherosclerosis
01/2022 - 06/2009
11Inflammation (Inflammations)
12/2021 - 06/2009
9Pain (Aches)
01/2021 - 08/2002
8Abdominal Pain (Pain, Abdominal)
01/2021 - 08/2002
6Neoplasms (Cancer)
01/2021 - 04/2011
5Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 07/2005
4Obesity
01/2022 - 09/2013
4Thrombosis (Thrombus)
04/2021 - 08/2017
4Ischemic Colitis
11/2013 - 05/2006
3Abdominal Aortic Aneurysm
10/2021 - 10/2010
3Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
01/2021 - 01/2009
3Non-alcoholic Fatty Liver Disease
12/2020 - 03/2014
3Hypersensitivity (Allergy)
10/2019 - 05/2004
3Necrosis
09/2013 - 06/2004
3Hypotension (Low Blood Pressure)
04/2009 - 07/2003
2Hypercholesterolemia
10/2021 - 11/2015
2Hemorrhage
01/2021 - 04/2013
2Crohn Disease (Crohn's Disease)
01/2021 - 10/2015
2Aneurysm (Aneurysms)
01/2021 - 01/2020
2Infections
01/2020 - 11/2019
2Rupture
01/2020 - 10/2010
2Visceral Pain
11/2019 - 07/2003
2Type 2 Diabetes Mellitus (MODY)
10/2018 - 08/2017
2congenital Sucrase-isomaltase deficiency
10/2018 - 01/2018
2Neoplasm Metastasis (Metastasis)
11/2015 - 08/2004
2Colitis
10/2015 - 05/2006
2Hypertension (High Blood Pressure)
09/2013 - 08/2010
2Cardiomegaly (Heart Hypertrophy)
07/2011 - 12/2007
2Craniocerebral Trauma (Head Injury)
06/2006 - 01/2006
2Vascular Calcification
07/2005 - 07/2005
2Septic Shock (Toxic Shock Syndrome)
07/2003 - 01/2003
1Heart Block
06/2022
1Atherosclerotic Plaque (Atheroma)
12/2021
1Sepsis (Septicemia)
12/2021
1Osteosarcoma (Osteogenic Sarcoma)
08/2021

Drug/Important Bio-Agent (IBA)

9CytokinesIBA
10/2021 - 02/2012
8alosetron (Lotronex)FDA Link
11/2013 - 10/2002
7Proteins (Proteins, Gene)FDA Link
01/2021 - 11/2011
6LipidsIBA
01/2022 - 04/2011
5Pharmaceutical PreparationsIBA
12/2021 - 04/2011
5Fatty Acids (Saturated Fatty Acids)IBA
12/2020 - 01/2012
4Apolipoproteins E (ApoE)IBA
01/2022 - 01/2018
4PPAR gammaIBA
10/2021 - 04/2009
4Biomarkers (Surrogate Marker)IBA
11/2020 - 08/2008
4LigandsIBA
11/2019 - 06/2009
4Messenger RNA (mRNA)IBA
01/2016 - 07/2005
4GhrelinIBA
07/2005 - 01/2003
3CholesterolIBA
12/2021 - 11/2015
3Angiotensin IIIBA
10/2021 - 08/2010
3AdipokinesIBA
01/2021 - 02/2015
3Glucose (Dextrose)FDA LinkGeneric
12/2020 - 01/2012
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2018 - 10/2010
3CalciumIBA
11/2011 - 07/2005
2Biological ProductsIBA
01/2022 - 10/2021
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2020
2Prescription DrugsIBA
12/2021 - 01/2021
2CXA-10IBA
10/2021 - 08/2010
2tegaserod (Zelnorm)FDA Link
01/2021 - 08/2005
2Alanine-glyoxylate transaminase (alanine-glyoxylate aminotransferase)IBA
01/2021 - 12/2020
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2021 - 01/2021
2Superoxides (Superoxide)IBA
01/2021 - 09/2013
2ApolipoproteinsIBA
01/2021 - 01/2018
2MicroRNAs (MicroRNA)IBA
01/2021 - 10/2015
2Neurotransmitter Agents (Neurotransmitter)IBA
01/2021 - 01/2021
2Opioid Analgesics (Opioids)IBA
01/2021 - 11/2019
2Pancreatic Elastase (Elastase)IBA
01/2021 - 10/2020
2Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2021 - 12/2020
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2021 - 08/2017
2ElastinIBA
10/2020 - 10/2010
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 01/2019
2Adenosine Triphosphate (ATP)IBA
01/2020 - 02/2004
2Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA
01/2019 - 11/2016
2Blood Glucose (Blood Sugar)IBA
10/2018 - 01/2003
2Sucrase (Sucrose alpha-D-Glucohydrolase)IBA
10/2018 - 01/2018
2Starch (Cornstarch)IBA
10/2018 - 01/2006
2Oligo-1,6-Glucosidase (Isomaltase)IBA
10/2018 - 01/2018
2Peptides (Polypeptides)IBA
01/2016 - 11/2004
2Corticotropin-Releasing HormoneIBA
11/2015 - 02/2012
25-HT3 Serotonin Receptors (5 HT3 Receptor)IBA
11/2013 - 10/2002
2Serotonin (5 Hydroxytryptamine)IBA
11/2013 - 07/2003
2Hormones (Hormone)IBA
09/2013 - 01/2009
2HydrogenIBA
09/2011 - 12/2008
2GTP Phosphohydrolases (GTPases)IBA
07/2011 - 12/2007
2ProgesteroneFDA LinkGeneric
01/2009 - 11/2002
2Estrogens (Estrogen)FDA Link
01/2009 - 11/2002
2MetallothioneinIBA
05/2005 - 04/2005
1Lactic Acid (Lactate)FDA LinkGeneric
06/2022
1Tryptophan (L-Tryptophan)FDA Link
01/2022
1Clopidogrel (Plavix)FDA Link
12/2021
1Prasugrel HydrochlorideFDA Link
12/2021
1Phospholipids (Phosphatides)FDA LinkGeneric
12/2021
1NucleotidesIBA
12/2021
1HDL LipoproteinsIBA
12/2021
1TicagrelorIBA
12/2021

Therapy/Procedure

15Therapeutics
01/2022 - 08/2002
2Aftercare (After-Treatment)
07/2020 - 04/2011
2Drug Therapy (Chemotherapy)
09/2010 - 01/2007